[1]
“Safety and Preliminary Immunogenicity of Recombinant Hepatitis B (Bio Farma) Vaccine in Adults and Children: A Phase 1 Clinical Trial”, Althea Med J, vol. 10, no. 4, pp. 242–251, Dec. 2023, doi: 10.15850/amj.v10n4.3279.